Tricuspid valve fungal endocarditis in a patient with breast cancer and an implantable chemotherapy venous access port

Published: December 18, 2023
Abstract Views: 413
pdf: 64
HTML: 1
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Fungal endocarditis, a rare and lethal infection, is etiologically connected with Candida and Aspergillus species. Among these two agents, Candida is a common nosocomial infection with increasing rates over the last years and mortality up to 40% in cases of systemic candidiasis. In the present paper, we describe the case of a 58yearold woman with metastatic breast cancer under palliative chemotherapy who was hospitalized for recurrent episodes of fever due to fungal endocarditis of the implantable venous access port. Such cases may elude the attention of the physician and need to be taken into account especially in oncologic patients with implantable devices under chemotherapy regimens. The treatment of Candida endocarditis can be difficult because of the formation of biofilms on prosthetic devices. The prognosis of these patients may be ameliorated with the combination of fungal and invasive treatment.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Fountoulakis, P., Siama, A., Kalogeris, A., Iliopoulou, M., Tsoukas, A., & Manolis, A. (2023). Tricuspid valve fungal endocarditis in a patient with breast cancer and an implantable chemotherapy venous access port. Global Cardiology, 1(1). https://doi.org/10.4081/cardio.2023.7

Similar Articles

You may also start an advanced similarity search for this article.